COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE

BACKGROUND: The COVID-19 pandemic has placed excessive strain on health care systems and this is especially evident in treatment decision-making for cancer patients. Glioblastoma (GBM) patients are among the most vulnerable due to increased incidence in the elderly (median age 64 years, peak between...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosha Gatson, Na, Barnholtz-Sloan, Jill S, Drappatz, Jan, Henriksson, Roger, Hottinger, Andreas, Hinoul, Piet, Kruchko, Carol, Puduvalli, Vinay, Tran, David, Wong, Eric, Glas, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Covid-19 and Neuro-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650331/
http://dx.doi.org/10.1093/neuonc/noaa215.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650331/
http://dx.doi.org/10.1093/neuonc/noaa215.100

Ejemplares similares